TABLE 2.
Variables | Readmission (n = 31) | Non readmission (n = 86) | P |
---|---|---|---|
Mean ± SD, n (%) | Mean ± SD, n (%) | ||
Age [years] | 42.7 ± 12.4 | 42.3 ± 11.3 | .85 |
Gender, male/female | 13(41.9)/18(58.1) | 40(46.5)/46(53.5) | .66 |
Admitted, involuntary/voluntary | 27(87.1)/4(12.9) | 76(88.4)/10(11.6) | 1.00 |
Number of hospital admissions | 6.0 ± 4.9 | 3.1 ± 2.7 | <.01* |
Diabetes mellitus, yes/no | 3(9.7)/28(90.3) | 3(3.5)/83(96.5) | .19 |
History of substance use, yes/no | 3(9.7)/28(90.3) | 3(3.5)/83(96.5) | .19 |
History of alcohol addiction, yes/no | 5(16.1)/26(83.9) | 7(8.1)/79(91.9) | .30 |
PANSS | 88.7 ± 19.3 | 88.9 ± 22.7 | .97 |
BPRS | 53.5 ± 16.9 | 48.1 ± 13.5 | .09* |
GAF a | 56.7 ± 8.4 | 60.3 ± 11.1 | .14 |
SAI‐J a | 13.8 ± 3.7 | 16.1 ± 4.0 | .01* |
DAI‐10 a | 3.8 ± 5.4 | 5.2 ± 4.6 | .18 |
SCoRS‐J a | 39.3 ± 12.1 | 32.2 ± 10.4 | .01* |
Clozapine, yes/no b | 0(0.0)/31(100.0) | 2(2.3)/84(97.7) | 1.00 |
Electro convulsive therapy, yes/no b | 7(22.6)/24(77.4) | 14(16.3)/72(83.7) | .43 |
Long‐acting injection use/not use b | 4(12.9)/27(87.1) | 24(27.9)/62(72.1) | .09* |
Chlorpromazine equivalent dose [mg] b | 1027.3 ± 602.2 | 934.1 ± 553.5 | .43 |
Social resources and support | |||
Members in household, alone/with family b | 17(54.8)/14(45.2) | 43(50.0)/43(50.0) | .64 |
Living arrangement, own home/residential care b | 28(90.3)/3(9.7) | 69(80.2)/17(19.8) | .20 |
Psychiatric day care, use/not use b | 15(48.4)/16(51.6) | 42(48.8)/44(51.2) | .97 |
Community occupational therapy, use/not use b | 7(22.6)/24(77.4) | 15(17.4)/71(82.6) | .53 |
Employment services, use/not use b | 3(9.7)/28(90.3) | 11(12.8)/75(87.2) | .76 |
Psychiatric home‐visit nursing care, use/not use b | 15(48.4)/16(51.6) | 47(54.7)/39(45.3) | .55 |
Measured at the beginning of psychoeducation.
Abbreviations: BPRS, Brief Psychiatric Rating Scale; DAI‐10, Drug Attitude Inventory‐10 items; GAF, Global Assessment of Functioning; PANSS, Positive and Negative Syndrome Scale; SAI‐J, Schedule for the Assessment of Insight Japanese version; SCoRS‐J, Schizophrenia Cognition Rating Scale Japanese version.
Measured at the end of psychoeducation.
Measured at discharge.
P < .1 vs. readmission; n = 31 (26.5%) for readmission, n = 86 (73.5%) for nonreadmission.